Viewing Study NCT02788656


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-20 @ 1:46 PM
Study NCT ID: NCT02788656
Status: TERMINATED
Last Update Posted: 2020-02-17
First Post: 2016-05-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
Sponsor: Brigham and Women's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congestive Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None heart failure View
None neprilysin View
None implantable hemodynamic monitor View
None angiotensin-receptor blocker View
None angiotensin-converting enzyme inhibitor View